Position in PMVP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,521,041
+$262,764 QoQ
Shares Held
2,627,643
0.0% QoQ
Ownership
4.92%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#4
of 64 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PMVP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Euclidean Capital LLC holds $27,571,414 across 6 Biotechnology names. PMVP ranks #3 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORIC |
Oric Pharmaceuticals, Inc.
|
989,410 | $10,715,310 | |
| 2 | FHTX |
Foghorn Therapeutics Inc.
|
1,573,761 | $7,679,953 | |
| 3 | PMVP |
PMV Pharmaceuticals, Inc.
This page
|
2,627,643 | $3,521,041 | |
| 4 | ALEC |
Alector, Inc.
|
1,307,858 | $2,628,794 | |
| 5 | SRZN |
Surrozen, Inc./DE
|
258,529 | $2,275,711 | |
| 6 | TNYA |
Tenaya Therapeutics, Inc.
|
1,015,705 | $750,605 |
All Filings in PMVP
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,521,041 | 2,627,643 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,258,277 | 2,627,643 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $3,258,277 | 2,627,643 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,284,553 | 2,627,643 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,678,700 | 2,627,643 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,785,301 | 2,627,643 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,864,130 | 2,627,643 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,967,740 | 2,627,643 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,915,188 | 2,627,643 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,256,781 | 2,627,643 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,466,993 | 2,627,643 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,145,693 | 2,627,643 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,133,728 | 2,627,643 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,933,214 | 2,545,242 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,147,055 | 2,336,909 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $20,331,108 | 2,336,909 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $27,809,217 | 2,336,909 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $33,300,953 | 2,336,909 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $48,654,445 | 2,336,909 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $53,982,597 | 2,336,909 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $82,540,427 | 2,769,813 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $133,520,406 | 3,908,677 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $137,460,992 | 4,179,416 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $257,075,878 | 4,179,416 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||